Clorox Co (CLX) is facing significant headwinds with a revenue decline of 5.68% year-over-year and a recent earnings miss in Q2 2026 at $1.39 versus an estimate of $1.4477. The stock is currently trading at $105.67, down from a 52-week high of $143.96, indicating a market cap of $12.78B which is under pressure due to inflation affecting margins, as noted by Wells Fargo's recent downgrade. With a P/E ratio of 17.11, the valuation appears stretched given the current financial landscape.